Market Overview

Stocks Hitting 52-Week Lows

Share:

Hatteras Financial (NYSE: HTS) shares reached a new 52-week low of $16.173. Hatteras Financial's trailing-twelve-month profit margin is -6.57%.

Myriad Genetics (NASDAQ: MYGN) shares touched a new 52-week low of $20.14. Myriad Genetics expressed concerns over CMS not valuing BRCA 2 gene in 81211 code, CMS 81211 payment rate. Mizuho Securities downgraded the stock from Buy to Neutral.

Gyrodyne Co. of America (NASDAQ: GYRO) shares touched a new 52-week low of $67.52. Gyrodyne Co. of America shares have dropped 4.52% over the past 52 weeks, while the S&P 500 index has gained 29.11% in the same period.

Can-Fite BioPharma (NYSE: CANF) shares reached a new 52-week low of $5.551 after the company's subsidiary OphthaliX (OTC: OPLI) reported that its phase III study with its licensed drug CF101 for moderate-to-severe dry eye syndrome did not meet primary efficacy endpoint.

Posted-In: 52-Week LowsNews Movers & Shakers Intraday Update Markets

 

Related Articles (GYRO + CANF)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Stocks Hitting 52-Week Highs

Morning Market Losers